Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV

NCT01852942 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT01852942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01852942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
July 16, 2019
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, hiv infections